Order Article Reprints

Gorenjak M, Gole B, Goričan L, Jezernik G, Prosenc Zmrzljak U, Pernat C, Skok P, Potočnik U. Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease. Pharmaceutics. 2024; 16(6):835. https://doi.org/10.3390/pharmaceutics16060835

Gorenjak, Mario, Boris Gole, Larisa Goričan, Gregor Jezernik, Uršula Prosenc Zmrzljak, Cvetka Pernat, Pavel Skok, and Uroš Potočnik. 2024. "Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease" Pharmaceutics 16, no. 6: 835. https://doi.org/10.3390/pharmaceutics16060835

Gorenjak, M., Gole, B., Goričan, L., Jezernik, G., Prosenc Zmrzljak, U., Pernat, C., Skok, P., & Potočnik, U. (2024). Single-Cell Transcriptomic and Targeted Genomic Profiling Adjusted for Inflammation and Therapy Bias Reveal CRTAM and PLCB1 as Novel Hub Genes for Anti-Tumor Necrosis Factor Alpha Therapy Response in Crohn’s Disease. Pharmaceutics, 16(6), 835. https://doi.org/10.3390/pharmaceutics16060835